Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.
Reason Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.
Reason Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.
Reason Lack of Assurance of Sterility: There are also CGMP Deviations.
Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.